These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Graft versus host disease prophylaxis today. Martelli MF; Aversa F Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726 [No Abstract] [Full Text] [Related]
4. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results. Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441 [No Abstract] [Full Text] [Related]
5. Prevention of graft-versus-host disease by using immunotoxins. Laurent G; Bouloux C Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408 [No Abstract] [Full Text] [Related]
6. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts. Jansen J; Hanks S; English D; Karaffa R; Akard L Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437 [No Abstract] [Full Text] [Related]
7. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation. Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917 [No Abstract] [Full Text] [Related]
8. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553 [TBL] [Abstract][Full Text] [Related]
11. Mixed chimerism after allogeneic bone marrow transplantation for leukemias. Bertheas MF; Lafage M; Blaise D; Stoppa AM; Viens P; Mannoni P; Maraninchi D Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():61-3. PubMed ID: 2390641 [No Abstract] [Full Text] [Related]
12. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia. Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544 [TBL] [Abstract][Full Text] [Related]
13. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644 [TBL] [Abstract][Full Text] [Related]
14. The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograft. Noga SJ; Davis JM; Vogelsang GB; Donnenberg AD; Thoburn C; Schepers K; Sproul J Prog Clin Biol Res; 1992; 377():411-8. PubMed ID: 1438439 [No Abstract] [Full Text] [Related]
15. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation. Champlin R Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294 [No Abstract] [Full Text] [Related]
16. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis. Marciniak E; Romond EH; Thompson JS; Henslee PJ Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328 [TBL] [Abstract][Full Text] [Related]
17. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft. Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494 [TBL] [Abstract][Full Text] [Related]
18. Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation. Haanen C; De Witte T; Plas A; Schattemberg T Haematologica; 1991 Mar; 76 Suppl 1():22-8. PubMed ID: 1864551 [TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation. de Witte T; Preijers F; Schattenberg A Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463 [No Abstract] [Full Text] [Related]
20. T cell depletion in allogenic bone marrow transplantation. Progress and problems. Marmont AM Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():229-32. PubMed ID: 2653509 [No Abstract] [Full Text] [Related] [Next] [New Search]